Kirsten Axelsen

Kirsten Axelsen, MS, is a senior policy advisor to DLA Piper, where she works with leaders in life sciences to navigate policy, competition, reimbursement, and public perception. Kirsten brings more than 25 years of experience in the innovative pharmaceutical industry. She has written, spoken, and published on the implications of biopharmaceutical regulation and policy on access to medicine. Kirsten is also a visiting scholar with the American Enterprise Institute and an Aspen Institute Health Innovator Fellow and founded the Preparedness and Treatment Equity Coalition. She holds an MS In Economics from the University of Texas, Austin.